GFAP and glioblastoma: Additionally, the GBM stemness was impaired, and complemented with enhanced differentiation, evidenced by the low-level of Nestin and high number of GFAP-expressing cells across the tumor (p < 0.05 and p < 0.01, Figure S7C).